KY
Kyverna Therapeutics, Inc.
KYTX · NASDAQ
$6.90 -1.71% (-$0.12)
1M -18.82%
Market Cap $419.5M
P/E Ratio -
Div. Yield -
ROE 81.91%
Piotroski F-Score Weak
1/9Valuation
74 /100
Cheap P/B 2.53x
PEG N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 70.73%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 81.91%
ROA 69.44%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 9.06x
Int. coverage -85.23x
Debt/Equity 0.20x
Stability
1 /100
Unstable EPS volatility 1,922,544.84%
Profitable years 0
Beta 1.99x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o KYTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Warner Biddle
Employees
149
Headquarters
Emeryville
Nadchodzące wydarzenia
11 LIS
Earnings
Upcoming earnings report